Stroke prevention in atrial fibrillation—An Asian stroke perspective

Hung‐Fat Tse(University of Hong Kong), Dayi Hu(Beihang University), Andreas Clemens(Boehringer Ingelheim (Germany)), Rungroj Krittayaphong(Siriraj Hospital), Annette B. Pizarro-Borromeo(Philippine Heart Center), Mohammad Zubaid(Kuwait University), Chunxue Wang(Beijing Tian Tan Hospital), Amit Vora, Chern‐En Chiang(National Yang Ming Chiao Tung University), Paul Lim, Balbir Singh(Universidad de Oviedo), Yong Jun Wang(Beijing Tian Tan Hospital), Moheeb Ahmed Ai-Abdullah(Prince Sultan University)
Heart Rhythm
March 15, 2013
10.1016/j.hrthm.2013.03.017
Cited by 153

Related Papers

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|New England Journal of Medicine|2013|603
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
|Journal of Arrhythmia|2017|193
Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese
|Nature Communications|2015|135
A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation.
|PubMed|2003|132
Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: A randomized placebo-controlled study
|American Heart Journal|2002|131